Celldex Therapeutics, Inc. (CLDX) Technical Analysis & Indicators
Celldex Therapeutics, Inc. (CLDX) — Price $29.04 (closing price, November 2, 2026) — Healthcare — Biotechnology — NASDAQ
Latest reported results:
Technical analysis of Celldex Therapeutics, Inc. (CLDX): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Celldex Therapeutics, Inc. is a biopharmaceutical company dedicated to developing antibody-based treatments, specifically monoclonal and bispecific antibodies, for a range of diseases. Their pipeline features therapeutic candidates aimed at both inflammatory conditions and various forms of cancer. Among their key clinical programs: CDX-0159 is a Phase I monoclonal antibody designed to bind to and inhibit the activity of the KIT receptor tyrosine kinase.